(Q34991505)

5 August 2017

1 reference

title

Non-cholinergic strategies for treating and preventing Alzheimer's disease (English)

1 reference

5 August 2017

0 references

P Murali Doraiswamy

1

1 reference

5 August 2017

1 January 2002

1 reference

5 August 2017

1 reference

5 August 2017

16

1 reference

5 August 2017

12

1 reference

5 August 2017

811-824

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200216120-00003

5 August 2017

0 references

cites work

Excitatory Amino Acid Transmitters

1 reference

12 December 2020

Anti-inflammatory drugs in the fight against Alzheimer's disease

1 reference

12 December 2020

Design and Study of Piracetam-like Nootropics, Controversial Members of the Problematic Class of Cognition-Enhancing Drugs

1 reference

12 December 2020

Neuropsychological changes after 30-day Ginkgo biloba administration in healthy participants.

1 reference

12 December 2020

Simvastatin-associated memory loss

1 reference

12 December 2020

Statins and the risk of dementia

1 reference

12 December 2020

Contributory mechanisms in the causation of neurodegenerative disorders

1 reference

12 December 2020

Cohort study of vitamin C intake and cognitive impairment.

1 reference

12 December 2020

Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain

1 reference

12 December 2020

Histochemically-reactive zinc in amyloid plaques, angiopathy, and degenerating neurons of Alzheimer's diseased brains

1 reference

12 December 2020

A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease

1 reference

12 December 2020

Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model

1 reference

12 December 2020

Biochemical markers related to Alzheimer's dementia in serum and cerebrospinal fluid

1 reference

12 December 2020

Donepezil in the treatment of Alzheimer's disease: long-term efficacy and safety

1 reference

12 December 2020

Cerebrolysin in Alzheimer's disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent.

1 reference

12 December 2020

Do nonsteroidal antiinflammatory drugs reduce the risk of Alzheimer's disease?

1 reference

12 December 2020

Rapid appearance of beta-amyloid precursor protein immunoreactivity in glial cells following excitotoxic brain injury

1 reference

12 December 2020

Treatment of Alzheimer's disease with clioquinol

1 reference

12 December 2020

Amyloid beta peptide (25-35) inhibits Na+-dependent glutamate uptake in rat hippocampal astrocyte cultures

1 reference

12 December 2020

Investigations of neurotoxicity and neuroprotection within the nucleus basalis of the rat.

1 reference

12 December 2020

Acetylcholine, aging, and Alzheimer's disease

1 reference

12 December 2020

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

1 reference

12 December 2020

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

1 reference

12 December 2020

A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients

1 reference

12 December 2020

Neuroprotective effect of memantine demonstrated in vivo and in vitro.

1 reference

12 December 2020

Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study.

1 reference

12 December 2020

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

1 reference

12 December 2020

Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: in vitro and in vivo characterization.

1 reference

12 December 2020

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

12 December 2020

Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease

1 reference

12 December 2020

A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease.

1 reference

12 December 2020

Defining meaningful change in Alzheimer's disease trials: the donepezil experience

1 reference

12 December 2020

Copper, iron and zinc in Alzheimer's disease senile plaques.

1 reference

12 December 2020

Galantamine: a randomized, double-blind, dose comparison in patients with Alzheimer's disease

1 reference

12 December 2020

Total serum homocysteine in senile dementia of Alzheimer type

1 reference

12 December 2020

Oxidative alterations in Alzheimer's disease.

1 reference

12 December 2020

NMDA channel blockers: memantine and amino-aklylcyclohexanes--in vivo characterization

1 reference

12 December 2020

Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: the Cache County study

1 reference

12 December 2020

Learning deficits induced by chronic intraventricular infusion of quinolinic acid--protection by MK-801 and memantine

1 reference

12 December 2020

NGF and the treatment of Alzheimer's disease

1 reference

12 December 2020

Ensaculin (KA-672 HCl): a multitransmitter approach to dementia treatment

1 reference

12 December 2020

Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease.

1 reference

12 December 2020

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

1 reference

12 December 2020

Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

1 reference

12 December 2020

Risk of Alzheimer's disease and duration of NSAID use.

1 reference

12 December 2020

Sustained improvements in patients with dementia of Alzheimer's type (DAT) 6 months after termination of Cerebrolysin therapy.

1 reference

12 December 2020

Estrogen deficiency and risk of Alzheimer's disease in women.

1 reference

12 December 2020

Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging.

1 reference

12 December 2020

A case-control analysis of nonsteroidal anti-inflammatory drugs and Alzheimer's disease: are they protective?

1 reference

12 December 2020

Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study.

1 reference

12 December 2020

Prospects for pharmacological intervention in Alzheimer disease

1 reference

12 December 2020

Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain

1 reference

12 December 2020

Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data

1 reference

12 December 2020

Neuroprotective and symptomatological action of memantine relevant for Alzheimer's disease--a unified glutamatergic hypothesis on the mechanism of action.

1 reference

12 December 2020

Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies

1 reference

12 December 2020

Effects of estrogen treatment on glutamate uptake in cultured human astrocytes derived from cortex of Alzheimer's disease patients

1 reference

12 December 2020

Probable Alzheimer's disease: gender-related issues

1 reference

12 December 2020

Pravastatin improves cerebral vasomotor reactivity in patients with subcortical small-vessel disease

1 reference

12 December 2020

Microglial release of nitric oxide by the synergistic action of beta-amyloid and IFN-gamma

1 reference

12 December 2020

Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats

1 reference

12 December 2020

The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease.

1 reference

12 December 2020

Histochemically reactive zinc in plaques of the Swedish mutant beta-amyloid precursor protein transgenic mice.

1 reference

12 December 2020

The Alzheimer's Disease Assessment Scale: patterns and predictors of baseline cognitive performance in multicenter Alzheimer's disease trials

1 reference

12 December 2020

Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity

1 reference

12 December 2020

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

12 December 2020

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

12 December 2020

MK-801, memantine and amantadine show neuroprotective activity in the nucleus basalis magnocellularis

1 reference

12 December 2020

The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomized clinical trial.

1 reference

12 December 2020

Efficacy of the peptidergic nootropic drug cerebrolysin in patients with senile dementia of the Alzheimer type (SDAT).

1 reference

12 December 2020

Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects

1 reference

12 December 2020

New approaches to diagnose and treat Alzheimer's disease: a glimpse of the future

1 reference

12 December 2020

Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease

1 reference

12 December 2020

Ginkgo for memory enhancement: a randomized controlled trial.

1 reference

12 December 2020

Are reactive oxygen species involved in Alzheimer's disease?

1 reference

12 December 2020

beta-Amyloid peptide fragment 25-35 potentiates the calcium-dependent release of excitatory amino acids from depolarized hippocampal slices.

1 reference

12 December 2020

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

1 reference

12 December 2020

Glutamate transmission and toxicity in Alzheimer's disease

1 reference

12 December 2020

Cognitive relapse after discontinuation of drug therapy in Alzheimer's disease: cholinesterase inhibitors versus nootropics.

1 reference

12 December 2020

A double-blind, placebo-controlled, multicenter study of Cerebrolysin for Alzheimer's disease

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.

1 reference

12 December 2020

Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.

1 reference

12 December 2020

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

1 reference

12 December 2020

The role of estrogen in the treatment and prevention of dementia: introduction.

1 reference

12 December 2020

Aging, energy, and oxidative stress in neurodegenerative diseases.

1 reference

12 December 2020

Estrogen, cognition, and a woman's risk of Alzheimer's disease

1 reference

12 December 2020

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

12 December 2020

Excitatory amino acids and synaptic transmission: the evidence for a physiological function

1 reference

12 December 2020

[A comparison of cholinesterase inhibitors and ginkgo extract in treatment of Alzheimer dementia]

1 reference

12 December 2020

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.

1 reference

12 December 2020

Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy.

1 reference

12 December 2020

Apparent independent action of nimodipine and glutamate antagonists to protect cultured neurons against glutamate-induced damage

1 reference

12 December 2020

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

1 reference

12 December 2020

Identification of cognitive impairment in the elderly: homocysteine is an early marker.

1 reference

12 December 2020

The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases

1 reference

12 December 2020

Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Cholinesterase inhibitors and Gingko extracts--are they comparable in the treatment of dementia? Comparison of published placebo-controlled efficacy studies of at least six months' duration.

1 reference

12 December 2020

Iron accumulation in Alzheimer disease is a source of redox-generated free radicals

1 reference

12 December 2020

Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion.

1 reference

12 December 2020

Cholinesterase inhibitors for Alzheimer's disease.

1 reference

12 December 2020

Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo

1 reference

12 December 2020

Glial modulating and neurotrophic properties of propentofylline and its application to Alzheimer's disease and vascular dementia.

1 reference

12 December 2020

10.2165/00023210-200216120-00003

Identifiers

DOI

1 reference

PubMed ID

12421115

Dimensions Publication ID

5 August 2017

0 references

1 reference

PubMed ID

12421115